BIOMAT Database Logo BIOMAT Database Logo

Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience. 2010

A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India.

OBJECTIVE To study the outcome of patients with sinonasal teratocarcinosarcoma treated at a single institution. METHODS We reviewed the medical records of 22 patients with histopathologically proven sinonasal teratocarcinosarcoma diagnosed during the period 1993-2007. Treatment was completed in 16 patients. RESULTS Fourteen patients underwent surgery (six received craniofacial resection, four open surgery and four endoscopic resection); this was followed by radiation therapy with or without chemotherapy in 11 patients. Two patients received chemoradiation as the definitive treatment. At median follow up in surviving patients of 34 months (range one to 180 months), only five were controlled. Disease recurred in 11 patients, with a median time to recurrence of seven months. The two-year disease-free survival rate and the overall survival rate were 28 and 46 per cent, respectively. CONCLUSIONS Sinonasal teratocarcinosarcoma appears to be an aggressive disease, with the majority of patients suffering locoregional failure. Multimodality treatment, in the form of a combination of surgery, radiation therapy and chemotherapy, appears to be the optimal approach.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010255 Paranasal Sinus Neoplasms Tumors or cancer of the PARANASAL SINUSES. Cancer of Paranasal Sinus,Neoplasms, Paranasal Sinus,Paranasal Sinus Cancer,Cancer, Paranasal Sinus,Cancers, Paranasal Sinus,Neoplasm, Paranasal Sinus,Paranasal Sinus Cancers,Paranasal Sinus Neoplasm
D002296 Carcinosarcoma A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed) Carcinosarcomas
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Sinonasal teratocarcinosarcoma.
February 2004, American journal of clinical oncology,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Sinonasal teratocarcinosarcoma.
May 2012, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Sinonasal teratocarcinosarcoma.
January 2010, American journal of otolaryngology,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Sinonasal teratocarcinosarcoma.
June 2012, JPMA. The Journal of the Pakistan Medical Association,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Sinonasal teratocarcinosarcoma.
June 2004, The Journal of otolaryngology,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
[Sinonasal teratocarcinosarcoma].
January 2014, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Management of sinonasal teratocarcinosarcoma: a systematic review.
January 2014, American journal of otolaryngology,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Sinonasal teratocarcinosarcoma: a clinical and pathological analysis.
February 2013, International journal of surgical pathology,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
[Sinonasal tract malignancies : a 14-year single institution experience].
December 2012, HNO,
A Budrukkar, and J P Agarwal, and S Kane, and M Siddha, and S Ghosh Laskar, and P Pai, and V Murthy, and M Sengar, and A D'Cruz
Sinonasal Undifferentiated Carcinoma: A 15-Year Single Institution Experience.
February 2019, Journal of neurological surgery. Part B, Skull base,
Copied contents to your clipboard!